Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

AZIYO BIOLOGICS, INC. (AZYO)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-23Mar-31-23Dec-31-22Sep-30-22Jun-30-22Mar-31-22Dec-31-21Sep-30-21
   10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q
Total revenues  48.450.749.247.446.546.047.449.0
            Revenue growth  4.1%10.3%3.8%-3.3%-5.7%0.7%11.0%15.9%
Cost of goods sold  31.029.530.029.830.229.028.427.3
Gross profit  17.421.319.217.616.317.019.021.7
            Gross margin  35.9%41.9%39.1%37.2%35.0%36.9%40.1%44.2%
Selling, general and administrative   [+]34.537.036.836.135.033.232.732.9
Research and development  7.08.58.910.210.69.89.37.9
EBITDA   [+]-20.4-20.5-22.8-25.0-25.6-22.3-19.2-15.4
            EBITDA margin  -42.2%-40.3%-46.4%-52.7%-55.0%-48.5%-40.5%-31.5%
Depreciation  2.12.12.02.02.02.93.73.7
EBITA  -22.5-22.5-24.8-27.0-27.6-25.2-22.9-19.2
            EBITA margin  -46.5%-44.4%-50.5%-57.0%-59.3%-54.8%-48.3%-39.1%
Amortization of intangibles  1.71.7  1.70.8  
EBIT   [+]-24.2-24.2-26.5-28.7-29.3-26.0-22.9-19.2
            EBIT margin  -50.0%-47.7%-54.0%-60.6%-63.0%-56.6%-48.3%-39.1%
Non-recurring items   [+]7.97.05.22.00.60.20.10.1
Interest expense  5.95.65.35.05.05.25.35.4
Other income (expense), net    4.2-0.8    
Pre-tax income  -33.9-32.7-32.9-36.5-34.9-27.9-24.8-21.1
Income taxes  0.00.00.00.00.00.10.10.1
            Tax rate    -0.1%     
Net income  -33.9-32.7-32.9-36.5-34.9-27.9-24.8-21.1
            Net margin  -70.1%-64.5%-66.8%-77.1%-75.1%-60.7%-52.4%-43.1%
   
Basic EPS   [+]($2.27)($2.28)($2.40)($2.85)($2.92)($2.51)($2.41)($2.52)
Diluted EPS   [+]($2.27)($2.28)($2.40)($2.85)($2.92)($2.51)($2.41)($2.52)
   
Shares outstanding (basic)   [+]15.014.313.712.812.011.110.38.4
Shares outstanding (diluted)   [+]15.014.313.712.812.011.110.38.4
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy